In 2003-2004，Mr. Zhang Jinjing conducted the design of the first cardiac remote monitoring network technology in the world based on mobile internet, iHolter,indicating that our heart remote monitoring technology had reached TOP level. Meanwhile, Yocaly was cooperating with Qilu Hospital of Shandong University on a clinical trial of large sample.

In 2005-2007，iHolter completed a three-year clinical trial of large sample (n=7160), and international roaming test in Qilu Hospital of Shandong University. Meanwhile, Yocaly officially settled in the Hi-zone, Jinan, a beautiful city of springs, and stepped into a historical stage of rapid development.

In 2008-2009, Yocaly created the world’s first data cloud platform providing hospitals with electrophysiological data services. The first batch of data cloud platform was available for providing IT and data service in some large hospitals in Shandong, Beijing and Shanghai.
 

On June 28, 2014, Premier Wen Jiabao, accompanied by leadership of Shandong province, visited heart remote real-time monitoring network, and gave the instructions “making this work universal among people as soon as possible”.
 

In 2010-2012, Yocaly received authorization of patents for its core technology in China, America, Austria, Taiwan, etc, providing service for above 100,000 patients with cardiovascular diseases.

In 2013, Mr. Giampiero MEANI, the Global Vice President of ST Group, one of the top 500 corporations, paid a visit to our company and signed a strategic cooperation agreement for collaboratively developing wearable heart monitoring products.  

 

In May 2014, Yocaly signed a strategic cooperation agreement with eCardio, a heart examination centre in US. The agreement stipulated that Yocaly should process and analyze data of 60,000 American patients from eCardio every year, which indicated that our data analysis technology had reached international TOP level.

 

On June 14, 2014, Yocaly beat the other 23 rivals in the final and won the first prize with 77.8 points in Sino-US Pioneering Competition held at Silicon Valley in San Francisco.

 

 

In 2015, data cloud platform was available in over 300  hospitals of levels and over 200 grassroots hospitals, providing service for over 400,000 patients with cardiovascular disease and storing 15,000,000 copies of real-time data and 400,000 copies of ambulatory data. The scale ranked the third in the world.

On March, 2015, Yocaly had achieved the second financing from Lepu Medical, the largest cardiovascular implantable device manufacturer in China. Both parties would carry out further cooperation on cardiovascular mobile medical field, which drove Yolcay to step into a historic stage of rapid development.